Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review

Document Type : Review Article


Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran.


Objective: Neurodegenerative diseases are considered an important cause of cognitive deficit and morbidity in old ages. Alzheimer’s disease (AD) is one of these disorders affecting about 40 million people in the world at the present time. Available drug therapy is mostly symptomatic and does not modify or stop disease progression. Recently, biologically active chemicals from herbs have been studied to develop new therapeutic drugs. Carvacrol has shown positive properties on many neurological diseases. This compound is expected to have the ability to affect AD pathogenesis and therefore, it is considered an anti-AD agent.
Materials and Methods: This review was conducted using PubMed, Google Scholar and Science Direct bibliographic databases until November 2021. For data collection, the following keywords were used: carvacrol, neuroprotective, cognition, anti-inflammatory, antioxidant, Acetylcolinesterase inhibitor (AChEI), Alzheimer's, Parkinson’s, epilepsy, stroke, ischemic brain injury, and neurodegenerative diseases.
Results: This review summarizes in vitro and in vivo studies on protective potential of carvacrol in neurodegenerative disorders and various underlying mechanisms, such as anti-inflammatory, antioxidant, and anticholinesterase effects. 
Conclusion: We gave an overview of available literature concerning neuroprotective effects of carvacrol in ameliorating the neurodegenerative diseases symptoms in vivo and in vitro. Particular attention is given to AD. Several neuro-pharmacological actions of carvacrol have been summarized in the current review article including anti-inflammatory, antioxidant, and AChEI properties.


Aghdash SN. 2021. Herbal medicine in the
treatment of pilepsy. Curr Drug Targets,
22: 356-367.
Aliev G, Obrenovich ME, Reddy VP, Shenk
JC, Moreira PI, Nunomura A, Zhu X,
Smith MA, Perry G. 2008. Antioxidant
therapy in Alzheimer's disease: theory
and practice. Mini Rev Med Chem, 8:
Ali-Shtayeh MS, Abu-Zaitoun SY, Dudai N,
Jamous RM. 2020. Downy Lavender Oil:
A promising source of antimicrobial,
antiobesity, and anti-Alzheimer's disease
agents. Evid Based Complement Alternat
Med, 5679408.
Anekonda TS, Reddy PH. 2005. Can herbs
provide a new generation of drugs for
treating Alzheimer's disease? 50: 361-
Ansari N, Khodagholi F. 2013. Natural
products as promising drug candidates for
the treatment of Alzheimer's disease:
molecular mechanism aspect. Curr
Neuropharmacol. 11: 414-429.
Aryal S, Skinner T, Bridges B, Weber JT.
2020. The Pathology of Parkinson's
disease and potential benefit of dietary
polyphenols. Molecules, 25: 4382.
Azizi Z, Choopani S, Salimi M, Majelssi N,
Naghdi N. 2021. Protein kinase C
involvement in neuroprotective effects of
thymol and carvacrol against toxicity
induced by Amyloid-β in rat hippocampal
neurons. Basic Clin Neurosci, In press.
Azizi Z, Ebrahimi S, Saadatfar E, Kamalinejad
M, Majlessi N. 2012. Cognitiveenhancing activity of thymol and
carvacrol in two rat models of dementia,
Behav Pharmacol. 23: 241-249.
Azizi Z, Salimi M, Amanzadeh A, Majelssi N,
Naghdi N. 2020. Carvacrol and thymol
attenuate cytotoxicity induced by amyloid
beta 25-35 via activating protein kinase C
and inhibiting oxidative stress in PC12
cells. Iran Biomed J, 24: 243-250.
Banik S, Akter M, Corpus Bondad SE, Saito
T, Hosokawa T, Kurasaki M. 2019.
Carvacrol inhibits cadmium toxicity
through combating against caspase
dependent/ independent apoptosis in
PC12 cells. Food Chem Toxicol, 134:
Baranauskaite J, Sadauskiene I, Liekis A,
Kasauskas A, Lazauskas R, Zlabiene U,
Masteikova R, Kopustinskiene DM,
Bernatoniene J. 2020. Natural compounds
rosmarinic acid and carvacrol counteract
Aluminium-induced oxidative stress.
Molecules, 25: 1807.
Baser KH. 2008. Biological and
pharmacological activities of carvacrol
and carvacrol bearing essential oils. Curr
Pharm Des, 14: 3106-3119.
Bianchini AE, Garlet QI, da Cunha JA,
Bandeira Junior G, Brusque ICM,
Salbego J, Heinzmann BM, Baldisserotto
B, Braz J. 2017. Monoterpenoids (thymol,
carvacrol and S-(+)-linalool) with
anesthetic activity in silver catfish
(Rhamdia quelen): evaluation of
acetylcholinesterase and GABAergic
activity. Med Biol Res, 50: e6346.
Boskabady MH, Tabanfar H, Gholamnezhad
Z, Sadeghnia HR. 2012. Inhibitory effect
of Zataria multiflora Boiss and carvacrol
on histamine (H(1)) receptors of guineapig tracheal chains. Fundam Clin
Pharmacol, 26: 609-620.
Burčul F, Blažević I, Radan M, Politeo O.
2020. Terpenes, phenylpropanoids, sulfur
and other essential oil constituents as
inhibitors of cholinesterases. Curr Med
Chem, 27: 4297-4343.
Carrasco A, Perez E, Cutillas AB, MartinezGutierrez R, Tomas V, Tudela J. 2016.
Origanum vulgare and Thymbra capitata
Essential Oils from Spain: determination
of aromatic profile and bioactivities. Nat
Prod Commun, 11: 113-120.
Carreiras MC, Mendes E, Perry MJ, Francisco
AP, Marco-Contelles J. 2013. The
multifactorial nature of Alzheimer's
disease for developing potential
therapeutics. Curr Top Med Chem, 13:
Celik F, Gocmez C, Bozkurt M, Kaplan I,
Azizi et al.
AJP, Vol. 12, No. 4, Jul-Aug 2022 384
Kamasak K, Akil E, Dogan E, Guzel A,
Uzar E. 2013. Neuroprotective effects of
carvacrol and pomegranate against
methotrexate-induced toxicity in rats. Eur
Rev Med Pharmacol Sci, 17: 2988-2993.
Chen W, Xu B, Xiao A, Liu L, Fang X, Liu R,
Turlova E, Barszczyk A, Zhong X, Sun
CL, Britto LR, Feng ZP, Sun HS. 2015.
TRPM7 inhibitor carvacrol protects brain
from neonatal hypoxic-ischemic injury.
Mol Brain, 8: 11.
Chenet AL, Duarte AR, Almeida FJS,
Andrade CMB, Oliveira MR. 2019.
Carvacrol depends on heme oxygenase-1
(HO-1) to exert antioxidant, antiinflammatory, and mitochondria-related
protection in the human neuroblastoma
SH-SY5Y cells line exposed to hydrogen
peroxide. Neurochem Res, 44: 884-896.
Cui ZW, Xie ZX, Wang BF, Zhong ZH, Chen
XY, Sun YH, Sun QF, Yang GY, Bian
LG. 2015. Carvacrol protects
neuroblastoma SH-SY5Y cells against
Fe(2+)-induced apoptosis by suppressing
activation of MAPK/JNK-NF-κB
signaling pathway. Acta Pharmacol Sin,
36: 1426-1436.
Dati LM, Ulrich H, Real CC, Feng ZP, Sun
HS, Britto LR. 2017. Carvacrol promotes
neuroprotection in the mouse
hemiparkinsonian model. Neuroscience,
356: 176-181.
Dauer W, Przedborski S. 2003. Parkinson's
disease: mechanisms and models. Neuron,
39: 889-909.
de Oliveira AS, de Souza LFS, Nunes RJ,
Johann S, Palomino-Salcedo DL, Ferreira
LLG, Andricopulo AD. 2020. Antioxidant
and antibacterial activity of sulfonamides
derived from carvacrol: A structureactivity relationship study. Curr Top Med
Chem, 20: 173-181.
de Souza MM, Andreolla MC, Ribeiro TC,
Gonçalves AE, Medeiros AR, de Souza
AS, Ferreira LLG, Andricopulo AD,
Yunes RA, de Oliveira AS. 2020.
Structure-activity relationships of
sulfonamides derived from carvacrol and
their potential for the treatment of
Alzheimer's disease. RSC Med Chem, 11:
De Vincenzi M, Stammati A, De Vincenzi A,
Silano M. 2004. Constituents of aromatic
plants: carvacrol. Fitoterapia, 75: 801-
Delgado-Marín L, Sánchez-Borzone M, García
DA. 2017. Neuroprotective effects of
gabaergic phenols correlated with their
pharmacological and antioxidant
properties. Life Sci, 175: 11-15.
Deng W, Lu H, Teng J. 2013. Carvacrol
attenuates diabetes-associated cognitive
deficits in rats. J Mol Neurosci, 51: 813-
Duyckaerts C, Delatour B, Potier MC. 2009.
Classification and basic pathology of
Alzheimer’s disease. Acta
neuropathologica, 118: 5-36.
Elhady MA, Khalaf AAA, Kamel MM, Noshy
PA. 2019. Carvacrol ameliorates
behavioral disturbances and DNA damage
in the brain of rats exposed to
propiconazole. Neurotoxicol, 70: 19-25.
Eratne D, Loi SM, Farrand S, Kelso W,
Velakoulis D, Looi JC. 2018. Alzheimer's
disease: clinical update on epidemiology,
pathophysiology and diagnosis. Australas
Psychiatry, 26: 347-357.
Friedman M. 2014. Chemistry and
multibeneficial bioactivities of carvacrol
(4-isopropyl-2-methylphenol), a
component of essential oils produced by
aromatic plants and spices. J Agric Food
Chem, 62: 7652-7670.
Gilling DH, Kitajima M, Torrey JR, Bright
KR. 2014. Antiviral efficacy and
mechanisms of action of oregano essential
oil and its primary component carvacrol
against murine norovirus. J Appl
Microbiol, 116: 1149-1163.
Guan X, Li X, Yang X, Yan J, Shi P, Ba L,
Cao Y, Wang P. 2019. The
neuroprotective effects of carvacrol on
hippocampal neuronal impairment by
ferroptosis mitigation. Life Sci, 235:
Haddadi H, Rajaei Z, Alaei H, Shahidani S.
2018. Chronic treatment with carvacrol
improves passive avoidance memory in a
rat model of Parkinson's disease. Arq
Neuropsiquiatr, 76: 71-77.
Hakimi Z, Salmani H, Marefati N, Arab Z,
Gholamnezhad Z, Beheshti F, Shafei MN,
Hosseini M. 2020. Protective effects of
carvacrol on brain tissue inflammation
and oxidative stress as well as learning
and memory in lipopolysaccharidechallenged rats. Neurotox Res, 37: 965-
Neuroprotective effects of carvacrol
AJP, Vol. 12, No. 4, Jul-Aug 2022 385
Hamzehloei L, Rezvani ME, Rajaei Z. 2019.
Effects of carvacrol and physical exercise
on motor and memory impairments
associated with Parkinson's disease. Arq
Neuropsiquiatr, 77: 493-500.
Hong DK, Choi BY, Kho AR, Lee SH, Jeong
JH, Kang BS, Kang DH, Park KH, Suh
SW. 2018. Carvacrol attenuates
hippocampal neuronal death after global
cerebral ischemia via inhibition of
transient receptor potential melastatin.
Cells, 7: 231.
Horishita T, Ogata Y, Horishita R, Fukui R,
Moriwaki K, Ueno S, Yanagihara N,
Uezono Y, Sudo Y, Minami K. 2020.
Carvacrol inhibits the neuronal voltagegated sodium channels Na(v)1.2,
Na(v)1.6, Na(v)1.3, Na(v)1.7, and
Na(v)1.8 expressed in Xenopus oocytes
with different potencies. J Pharmacol Sci,
142: 140-147.
Jeong JH, Lee SH, Kho AR, Hong DK, Kang
DH, Kang BS, Park MK, Choi BY, Choi
HC, Lim MS, Suh SW. 2020. The
transient receptor potential melastatin 7
(TRPM7) inhibitors suppress seizureinduced neuron death by inhibiting zinc
neurotoxicity. Int J Mol Sci, 21: 7897.
Jukic M, Politeo O, Maksimovic M, Milos M,
Milos M. 2007. In vitro AChEI properties
of thymol, carvacrol and their derivatives
thymoquinone and thymohydroquinone.
Phytother Res, 21: 259-261.
Kachur K, Suntres Z. 2020. The antibacterial
properties of phenolic isomers, carvacrol
and thymol. Crit Rev Food Sci Nutr, 60:
Karkabounas S, Kostoula OK, Daskalou T,
Veltsistas P, Karamouzis M, Zelovitis I,
Metsios A, Lekkas P, Evangelou AM,
Kotsis N, Skoufos I. 2006.
Anticarcinogenic and antiplatelet effects
of carvacrol. Exp Oncol, 28: 121-125.
Kaufmann D, Dogra AK, Wink M. 2011.
Myrtenal inhibits acetylcholinesterase, a
known Alzheimer target. J Pharm
Pharmacol, 63: 1368-1371.
Khalil A, Kovac S, Morris G, Walker MC.
2017. Carvacrol after status epilepticus
(SE) prevents recurrent SE, early seizures,
cell death, and cognitive decline.
Epilepsia, 58: 263-273.
Khan I, Bhardwaj M, Shukla S, Min SH, Choi
DK, Bajpai VK, Huh YS, Kang SC. 2019.
Carvacrol inhibits cytochrome P450 and
protects against binge alcohol-induced
liver toxicity. Food Chem Toxicol, 131:
Kim JE, Lee JE, Huh MJ, Lee SC, Seo SM,
Kwon JH, Park IK. 2019. Fumigant
antifungal activity via reactive oxygen
species of thymus vulgaris and satureja
hortensis Essential Oils and constituents
against Raffaelea quercus-mongolicae and
Rhizoctonia solani. Biomolecules, 9: 561.
Kurt BZ, Gazioglu I, Dag A, Salmas RE,
Kayık G, Durdagi S, Sonmez F. 2017.
Synthesis, anticholinesterase activity and
molecular modeling study of novel
carbamate-substituted thymol/carvacrol
derivatives. Bioorg Med Chem, 25: 1352-
Le Heron C, Plant O, Manohar S, Ang YS,
Jackson M, Lennox G, Hu MT, Husain
M. 2018. Distinct effects of apathy and
dopamine on effort-based decisionmaking in Parkinson's disease. Brain,
141: 1455-1469.
Lee B, Yeom M, Shim I, Lee H, Hahm DH.
2020. Inhibitory effect of carvacrol on
lipopolysaccharide-induced memory
impairment in rats. Korean J Physiol
Pharmacol, 24: 27-37.
León R, Garcia AG, Marco-Contelles J. 2013.
Recent advances in the multitargetdirected ligands approach for the
treatment of Alzheimer's disease. Med
Res Rev, 33: 139-189.
Li WT, Zhang SY, Zhou YF, Zhang BF, Liang
ZQ, Liu YH, Wei Y, Li CK, Meng XJ,
Xia M, Dan Y, Song JN. 2015. Carvacrol
attenuates traumatic neuronal injury
through store-operated Ca(2+) entryindependent regulation of intracellular
Ca(2+) homeostasis. Neurochem Int, 90:
Li Z, Hua C, Pan X, Fu X, Wu W. 2016.
Carvacrol exerts neuroprotective effects
via suppression of the inflammatory
response in middle cerebral artery
occlusion rats. Inflammation, 39: 1566-
Lins LCRF, Souza MF, Bispo JMM, Gois
AM, Melo TCS, Andrade RAS, QuintansJunior LJ, Ribeiro AM, Silva RH, Santos
JR, Marchioro M. 2018. Carvacrol
prevents impairments in motor and
neurochemical parameters in a model of
progressive parkinsonism induced by
reserpine. Brain Res Bull, 139: 9-15.
Azizi et al.
AJP, Vol. 12, No. 4, Jul-Aug 2022 386
Liu W, Ge T, Pan Z, Leng Y, Lv J, Li B. 2017.
The effects of herbal medicine on
epilepsy. Oncotarget, 8: 48385-48397.
Majlessi N, Choopani S, Kamalinejad M,
Azizi Z. 2012. Amelioration of amyloid
β-induced cognitive deficits by Zataria
multiflora Boiss. essential oil in a rat
model of Alzheimer's disease. CNS
Neurosci Ther, 18: 295-301.
Manouchehrabadi M, Farhadi M, Azizi Z,
Torkaman-Boutorabi A. 2020. Carvacrol
protects against 6-Hydroxydopamineinduced neurotoxicity in In vivo and In
vitro models of Parkinson's disease.
Neurotox Res, 37: 156-170.
Mazo NA, Echeverria V, Cabezas R, AvilaRodriguez M, Tarasov VV, Yarla NS,
Aliev G, Barreto GE. 2017. Medicinal
plants as protective strategies against
Parkinson's disease. Curr Pharm Des, 23:
Medhat D, El-Mezayen HA, El-Naggar ME,
Farrag AR, Abdelgawad ME, Hussein J,
Kamal MH. 2019. Evaluation of urinary
8-hydroxy-2-deoxyguanosine level in
experimental Alzheimer's disease: Impact
of carvacrol nanoparticles. Mol Biol Rep,
46: 4517-4527.
Mediouni S, Jablonski JA, Tsuda S, Barsamian
A, Kessing C, Richard A, Biswas A,
Toledo F, Andrade VM, Even Y,
Stevenson M, Tellinghuisen T, Choe H,
Cameron M, Bannister TD, Valente ST.
2020. Oregano oil and its principal
component, carvacrol, inhibit HIV-1
Fusion into target cells. J Virol, 94:
Mimica N, Presecki P. 2009. Side effects of
approved antidementives. Psychiatr
Danub, 21: 108-113.
Naeem K, Tariq Al Kury L, Nasar F, Alattar
A, Alshaman R, Shah FA, Khan AU, Li
S. 2021. Natural dietary supplement,
carvacrol, alleviates LPS-induced
oxidative stress, neurodegeneration, and
depressive-like behaviors via the
Nrf2/HO-1 pathway. J Inflamm Res, 14:
Noshy PA, Elhady MA, Khalaf AAA, Kamel
MM, Hassanen EI. 2018. Ameliorative
effect of carvacrol against propiconazoleinduced neurobehavioral toxicity in rats.
Neurotoxicology, 67: 141-149.
Orhan I, Kartal M, Kan Y, Sener B. 2008.
Activity of essential oils and individual
components against acetyl- and
butyrylcholinesterase. Z Naturforsch C J
Biosci, 63: 547-553.
Park JH, Jeon YJ, Lee CH, Chung N, Lee HS.
2017. Insecticidal toxicities of carvacrol
and thymol derived from Thymus vulgaris
Lin. against Pochazia shantungensis Chou
&Lu., newly recorded pest. Sci Rep, 7:
Peters M, Trembovler V, Alexandrovich A,
Parnas M, Birnbaumer L, Minke B,
Shohami E. 2012. Carvacrol together with
TRPC1 elimination improve functional
recovery after traumatic brain injury in
mice. J Neurotrauma, 29: 2831-2834.
Prieto JM, Jacopini P, Cioni P, Chericoni S.
2007. In vitro activity of the essential oils
of Origanum vulgare, Satureja montana
and their main constituents in
peroxynitrite-induced oxidative processes.
Food Chem, 104: 889-895.
Rojas-Armas JP, Arroyo-Acevedo JL,
Palomino-Pacheco M, Herrera-Calderón
O, Ortiz-Sánchez JM, Rojas-Armas A,
Calva J, Castro-Luna A, Hilario-Vargas J.
2020. The Essential Oil of cymbopogon
citratus Stapt and carvacrol: An approach
of the antitumor effect on 7, 12-
(DMBA)-induced breast cancer in female
rats. Molecules, 25: 3284.
Sadegh M, Sakhaie MH. 2018. Carvacrol
mitigates proconvulsive effects of
lipopolysaccharide, possibly through the
hippocampal cyclooxygenase-2
inhibition. Metab Brain Dis, 33: 2045-
Shahrokhi Raeini A, Hafizibarjin Z, Rezvani
ME, Safari F, Afkhami Aghda F, Zare
Mehrjerdi F. 2020. Carvacrol suppresses
learning and memory dysfunction and
hippocampal damages caused by chronic
cerebral hypoperfusion. Naunyn
Schmiedebergs Arch Pharmacol, 393:
Sharifi-Rad M, Varoni EM, Iriti M, Martorell
M, Setzer WN, Del Mar Contreras M,
Salehi B, Soltani-Nejad A, Rajabi S,
Tajbakhsh M, Sharifi-Rad J. 2018.
Carvacrol and human health: A
comprehensive review. Phytother Res, 32:
Silva ER, de Carvalho FO, Teixeira LGB,
Santos NGL, Felipe FA, Santana HSR,
Shanmugam S, Quintans Júnior LJ, de
Neuroprotective effects of carvacrol
AJP, Vol. 12, No. 4, Jul-Aug 2022 387
Souza Araújo AA, Nunes PS. 2018.
Pharmacological effects of carvacrol in in
vitro studies: A review. Curr Pharm Des,
24: 3454-3465.
Sisti FM, Dos Santos NAG, do Amaral L, Dos
Santos AC. 2021. The neurotrophic-like
effect of carvacrol: perspective for axonal
and synaptic regeneration. Neurotox Res,
39: 886-896.
Sivaranjani A, Sivagami G, Nalini N. 2016.
Chemopreventive effect of carvacrol on
1,2-dimethylhydrazine induced
experimental colon carcinogenesis. J
Cancer Res Ther, 12: 755-762.
Suganthi RU, Manpal S. 2013. Biological and
pharmacological of actions carvacrol and
its effects on poultry: an updated review.
World J Pharm Pharm Sci, 2: 3581-3595.
Swomley AM, Butterfield DA. 2015.
Oxidative stress in Alzheimer’s disease
and mild cognitive impairment: evidence
from human data provided by redox
proteomics. Arch Toxicol, 89: 1669-1680.
Tiefensee Ribeiro C, Gasparotto J, Petiz LL,
Brum PO, Peixoto DO, Kunzler A, da
Rosa Silva HT, Bortolin RC, Almeida RF,
Quintans-Junior LJ, Araújo AA, Moreira
JCF, Gelain DP. 2019. Oral
administration of carvacrol/betacyclodextrin complex protects against 6-
hydroxydopamine-induced dopaminergic
denervation. Neurochem Int, 126: 27-35.
Vaiserman A, Koliada A, Lushchak O. 2020.
Neuroinflammation in pathogenesis of
Alzheimer's disease: phytochemicals as
potential therapeutics. Mech Ageing Dev,
189: 111259.
Wang P, Luo Q, Qiao H, Ding H, Cao Y, Yu J,
Liu R, Zhang Q, Zhu H, Qu L. 2017. The
neuroprotective effects of carvacrol on
ethanol-induced hippocampal neurons
impairment via the antioxidative and
antiapoptotic pathways. Oxid Med Cell
Longev, 4079425.
Wang Z, He C, Shi JS. 2020. Natural products
for the treatment of neurodegenerative
diseases. Curr Med Chem, 27: 5790-5828.
Yu H, Zhang ZL, Chen J, Pei A, Hua F, Qian
X, He J, Liu CF, Xu X. 2012. Carvacrol, a
food-additive, provides neuroprotection
on focal cerebral ischemia/reperfusion
injury in mice. PLoS One, 7: e33584.
Zamanian M, Kujawska M, Zadeh MN,
Hassanshahi A, Ramezanpour S, Kamiab
Z, Bazmandegan G. 2021. Carvacrol as a
potential neuroprotective agent for
neurological diseases: A systematic
review article. CNS Neurol Disord Drug
Targets, 20: 942-953.
Zare Mehrjerdi F, Niknazar S, Yadegari M,
Akbari FA, Pirmoradi Z, Khaksari M.
2020. Carvacrol reduces hippocampal cell
death and improves learning and memory
deficits following lead-induced
neurotoxicity via antioxidant activity.
Naunyn Schmiedebergs Arch Pharmacol,
393: 1229-1237.
Zhang F, Jiang L. 2015. Neuroinflammation in
Alzheimer's disease. Neuropsychiatr Dis
Treat, 11: 243-256.
Zhang J, Ma S, Du S, Chen S, Sun H. 2019.
Antifungal activity of thymol and
carvacrol against postharvest pathogens
Botrytis cinerea. J Food Sci Technol, 56:
Zhao Y, Gong CX. 2017. From chronic
cerebral hypoperfusion to Alzheimer-like
brain pathology and neurodegeneration.
Cell Mol Neurobiol, 35: 101-110.
Zhong Z, Wang B, Dai M, Sun Y, Sun Q,
Yang G, Bian L. 2013. Carvacrol alleviates
cerebral edema by modulating AQP4
expression after intracerebral hemorrhage
in mice. Neurosci Lett, 555: 24-39.
Zotti M, Colaianna M, Morgese MG, Tucci P,
Schiavone S, Avato P, Trabace L. 2013.
Carvacrol: from ancient flavoring to
neuromodulatory agent. Molecules, 18: